STOCK TITAN
  1. Home
  2. Sec-filings
  3. GH
  4. [144] Guardant Health, Inc. SEC Filing

[144] Guardant Health, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock GH logo
Guardant Health

NASDAQ:GH

GH Rankings

#1719 Ranked by Market Cap
N/A Ranked by Dividends

GH Latest News

Jul 15, 2025
First Patient Enrolled in National Cancer Institute’s Vanguard Study Evaluating Guardant Health’s Shield Multi-Cancer Detection Test
Jul 14, 2025
Guardant Health to Report Second Quarter 2025 Financial Results on July 30, 2025
Jun 10, 2025
Guardant Health Wins Fast Company’s 2025 World Changing Ideas Award for Shield Blood Test for Colorectal Cancer Screening
Jun 9, 2025
New Study Published in ESMO Open Highlights Guardant Reveal's Performance in Detecting Minimal Residual Disease in Patients with Early-Stage Breast Cancer
Jun 3, 2025
FDA Grants Breakthrough Device Designation to Guardant Health’s Shield Multi-Cancer Detection (MCD) Test

GH Latest SEC Filings

Jul 18, 2025
[Form 4] Guardant Health, Inc. Insider Trading Activity
Jul 18, 2025
[Form 4] Guardant Health, Inc. Insider Trading Activity
Jul 18, 2025
[Form 4] Guardant Health, Inc. Insider Trading Activity
Jul 17, 2025
[144] Guardant Health, Inc. SEC Filing
Jul 16, 2025
[Form 4] Guardant Health, Inc. Insider Trading Activity

GH Stock Data

6.35B
118.23M
4.71%
98.48%
6.4%
Diagnostics & Research
Services-medical Laboratories
Link
United States
PALO ALTO